The FDA ended shortage-related compounding in 2025 and, on April 30, 2026, proposed keeping tirzepatide off the 503B bulks list permanently
In this article, "GLP-1 patch" refers to a marketing label used onlinenot an FDA-recognized class of GLP-1 medication
If eligible, request prescription GLP-1 medication like Wegovy pills.
Kooij, Derek IJsbrand Koster, Emma Eeltink, Mieneke Luijendijk, Lisa Drost, Fabien Ducrocq, Roger A.H
Yet it also brings challenges in access, regulation, and trust
Notably, LEO activates the METTL3/AKT1S1 axis to induce autophagy, ameliorating macrophage lipid accumulation and suppressing atherosclerotic plaque formation (Yu et al., 2024)